Company / Accounts Receivable
Bruker Accounts Receivable History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$544.9M
FY2025
5-year range
$416.9M / $565.5M
FY2021-FY2025
Trend
-3.6%
vs FY2024
Sector context
#46 of 143
Health Care
What the data says
At $545M, Bruker's accounts receivable ranks #46 of 143 in the Health Care sector. Accounts Receivable has fluctuated over the past 10 years, ranging from $244M in FY2016 to $566M in FY2024.
Based on SEC 10-K filings.
$545M in FY2025 with a 5-year CAGR of +10.2%.
Improved from $492M to $545M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +4.9%
- 5-Year CAGR
- +10.2%
- 10-Year CAGR
- -
Sector benchmark
#46 of 143 in Health CareTop 32% of 143This company $544.9M Sector average $1.3B
▼
-59.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +10.2%, indicating consistent growth.
- In FY2025, accounts receivable decreased 3.6% year-over-year.
- Ranks #46 out of 143 companies in the Health Care sector.
- Peak accounts receivable was recorded in FY2024.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $544.9M | -3.6% |
| FY2024 | $565.5M | +14.9% |
| FY2023 | $492.0M | +4.1% |
| FY2022 | $472.7M | +13.4% |
| FY2021 | $416.9M | +24.3% |
| FY2020 | $335.3M | -7.4% |
| FY2019 | $362.2M | +1.4% |
| FY2018 | $357.2M | +11.9% |
| FY2017 | $319.3M | +30.9% |
| FY2016 | $243.9M | +3.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026